Difference between revisions of "Caspofungin (Cancidas)"
Jump to navigation
Jump to search
(Created page with "Lipopeptide antifungal, no known antineoplastic properties. Category:Drug index Category:Intravenous medications Category:Antifungals Category:Drugs FDA approv...") |
m (Text replacement - "[[File:" to "[[:File:") |
||
(6 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
Lipopeptide antifungal, no known antineoplastic properties. | Lipopeptide antifungal, no known antineoplastic properties. | ||
− | [[Category: | + | == Patient Drug Information== |
+ | *[https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/CASPERCID-June-2018-final.pdf?la=en Caspofungin (Cancidas) Package Insert]<ref>[https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/CASPERCID-June-2018-final.pdf?la=en Caspofungin (Cancidas) Package Insert]</ref><ref>[[:File:Caspofungin.pdf | Caspofungin (Cancidas) package insert (locally hosted backup)]]</ref> | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Brand names:''' Cagin, Cancidas, Capsain, Caspogin, Caspoliv, Casponova, Guficap, Kabifungin, Letocan, Profung, Wofungin | ||
+ | |||
+ | ==References== | ||
+ | |||
+ | [[Category:Drugs]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Antifungals]] | [[Category:Antifungals]] | ||
− | [[Category: | + | [[Category:FDA approved in 2001]] |
Latest revision as of 04:14, 20 September 2021
Lipopeptide antifungal, no known antineoplastic properties.
Patient Drug Information
Also known as
- Brand names: Cagin, Cancidas, Capsain, Caspogin, Caspoliv, Casponova, Guficap, Kabifungin, Letocan, Profung, Wofungin